Pantoprazol Zentiva (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazol Zentiva, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, NSAID‑induced gastric ulcer and Zollinger‑Ellison syndrome in adult patients.\n\nGNH India supplies Pantoprazol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Zentiva, a proton pump inhibitor, acts on the gastric acid secretion pathway to manage several acid‑related disorders.\n\n- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal lining.\n- Erosive esophagitis: facilitates mucosal repair by decreasing gastric acidity.\n- NSAID‑induced gastric ulcer: protects the gastric mucosa by limiting acid‑mediated injury.\n- Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazol Zentiva may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often resolves without intervention.\n- Diarrhea: loose stools that may be transient.\n- Nausea: feeling of queasiness, usually mild.\n- Abdominal pain: discomfort in the stomach region.\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and breathing difficulty.\n- Low magnesium levels (hypomagnesemia): can cause muscle cramps, seizures, or cardiac arrhythmias with prolonged use.\n- Clostridioides difficile infection: severe colitis presenting with watery diarrhea and abdominal pain.

Before initiating therapy, consider the following precautions.\n\n- Assess renal function: dose adjustment may be required in severe renal impairment.\n- Monitor magnesium: prolonged treatment can lead to hypomagnesemia.\n- Avoid abrupt discontinuation: may cause rebound acid hypersecretion.\n- Use with caution in hepatic disease: limited data on safety.\n- Pregnancy and lactation: discuss potential risks with a healthcare professional.\n- Store at ambient temperature: keep in the original container, protect from moisture and light.

Pantoprazol Zentiva can interact with several medicines, affecting their efficacy or safety.\n\nMajor Interactions (Avoid):\n- Ketoconazole: reduced absorption and effectiveness of ketoconazole.\n- Atazanavir: decreased plasma concentrations of atazanavir.\n- Clopidogrel: diminished activation of clopidogrel, reducing antiplatelet effect.\n- Warfarin: possible increase in INR, requiring closer monitoring.\n\nModerate Interactions (Monitor Closely):\n- Digoxin: increased serum digoxin levels, risk of toxicity.\n- Methotrexate: reduced clearance leading to higher systemic exposure.\n- Phenytoin: decreased phenytoin concentrations, may require dose adjustment.